P E Lønning Selected Research

P E Lønning Research Topics

Disease

34	Breast Neoplasms (Breast Cancer) 01/2021 - 06/2000
18	Neoplasms (Cancer) 01/2021 - 09/2000
3	Disease Progression 06/2001 - 08/2000
2	Lymphatic Metastasis 10/2018 - 08/2000
2	Melanoma (Melanoma, Malignant) 10/2011 - 09/2008
1	Triple Negative Breast Neoplasms 01/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2012
1	Myeloid Leukemia (Leukemia, Myelocytic) 10/2011
1	Preleukemia 10/2011
1	Papillary Thyroid Cancer 10/2011
1	Hypersensitivity (Allergy) 10/2009
1	Ovarian Neoplasms (Ovarian Cancer) 04/2006
1	Paraneoplastic Cerebellar Degeneration 04/2006
1	Fibroadenoma 09/2001
1	Noninfiltrating Intraductal Carcinoma (DCIS) 07/2001
1	Neoplasm Metastasis (Metastasis) 06/2001
1	Infections 01/2001
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2001
1	HIV Infections (HIV Infection) 01/2001
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2001
1	Endometrial Neoplasms (Endometrial Cancer) 06/2000

Drug/Important Bio-Agent (IBA)

14	Aromatase InhibitorsIBA 03/2011 - 06/2000
8	exemestane (Aromasin)FDA Link 03/2011 - 06/2000
8	Tamoxifen FDA LinkGeneric 03/2011 - 06/2000
8	Estrogens (Estrogen)FDA Link 03/2011 - 07/2000
4	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2008 - 08/2000
4	Insulin-Like PeptidesIBA 03/2005 - 01/2001
2	Messenger RNA (mRNA)IBA 10/2011 - 01/2005
2	Letrozole (Femara)FDA LinkGeneric 03/2011 - 03/2009
2	Anastrozole (Arimidex)FDA LinkGeneric 03/2011 - 03/2009
2	Estradiol (Delestrogen)FDA LinkGeneric 10/2009 - 01/2005
2	Hormones (Hormone)IBA 03/2009 - 09/2007
2	Estrogen ReceptorsIBA 01/2005 - 09/2001
2	Selective Estrogen Receptor Modulators (SERM)IBA 12/2001 - 06/2000
2	Aromatase (CYP19)IBA 12/2001 - 06/2000
2	Megestrol Acetate (Borea)FDA LinkGeneric 09/2000 - 08/2000
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	olaparibIBA 01/2021
1	Protein Isoforms (Isoforms)IBA 03/2012
1	Proteins (Proteins, Gene)FDA Link 03/2012
1	RetinoidsIBA 10/2011
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 10/2009
1	Estrone FDA Link 10/2009
1	Etoposide (VP 16)FDA LinkGeneric 09/2008
1	Proteoglycans (Proteoglycan)IBA 09/2008
1	Carboplatin (JM8)FDA LinkGeneric 09/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2008
1	Cisplatin (Platino)FDA LinkGeneric 09/2008
1	Temozolomide (Temodar)FDA LinkGeneric 09/2008
1	Trastuzumab (Herceptin)FDA Link 01/2007
1	LipidsIBA 11/2006
1	AntibodiesIBA 04/2006
1	Edetic Acid (EDTA)FDA Link 04/2006
1	Octreotide (Sandostatin)FDA LinkGeneric 03/2005
1	EnzymesIBA 01/2005
1	Complementary DNA (cDNA)IBA 09/2001
1	Insulin-Like Growth Factor Binding Protein 3IBA 07/2001
1	Diethylstilbestrol (Stilbestrol)FDA Link 05/2001
1	formestaneIBA 04/2001
1	Nonsense Codon (Nonsense Mutation)IBA 03/2001
1	insulin-like growth factor binding protein-3 proteaseIBA 01/2001
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 01/2001
1	Insulin-Like Growth Factor Binding Protein 2IBA 01/2001
1	Estrogen Receptor Modulators (Antiestrogen)IBA 01/2001
1	Aminoglutethimide (Cytadren)FDA Link 08/2000
1	Raloxifene Hydrochloride (Evista)FDA Link 06/2000

Therapy/Procedure

19	Therapeutics 11/2013 - 06/2000
6	Drug Therapy (Chemotherapy) 01/2021 - 06/2000
2	Neoadjuvant Therapy 06/2011 - 03/2003
1	Radiotherapy 10/2018
1	Mastectomy (Mammectomy) 10/2009
1	Time-to-Treatment 09/2000
1	Aftercare (After-Treatment) 06/2000